Swine Flu Stocks

This is a list of stocks that could profit on the swine flu scare.

Our first choice is NanoViricides (NNVC Charts & Stock Quote) which says its Flu-Cide drug is designed to destroy All influenza A viruses including swine and bird Flu.

For more, read Kirk Lindstrom's article:

Swine Flu Cure: NanoViricides Flu-Cide Drug Designed to Destroy Influenza A Viruses

NanoViricides"Flu-Cide" is a cure, not a vaccine. NanoViricides stock did quite well a few years ago during a bird-flu scare when I bought my first shares at $1.01 and took profits at $2.80. See below for long-term chart showing how it surged t0 $3.75 during the 2006 Bird Flu scare. After NNVC came back to Earth after that scare, I started accumulating shares in "Kirk Lindstrom's Investment Letter Explore" (FREE Sample Issue) and personal portfolios to load up for the next run.

From All Allan

Friday's market cap and close:

NNVC $98M.....$0.80
NVAX $98M.....$1.42
SVA $84M......$1.97
AVII $76M.....$0.89
BRCX $85M.....$2.26

7 Top Stocks from StockRake

BCRX, DVAX, GNVC, HEB, INSM, NVAX and SVA

From OTC Investor

Linkwell Corporation (LWLLE.OB: 0.14 +180.00%) shares moved up more than 250 percent on speculation that demand for disinfectant products could rise in China. The company is the number one producer of disinfectants with 56 product lines in China, but still controls just a fraction of the $6.25 billion market. Investors are betting that the swine flu outbreak will generate demand for disinfectants in China and around the world.

NanoViricides Inc. (NNVC.OB: 1.05 +31.25%) shares jumped more than 40 percent after it re-announced the development of its flu drugs. The company’s FluCide drug has reportedly been effective in targeting two key flu strains in animal testing, but the drug still has yet to go through FDA drug trials in order to be sold commercially. However, investors seem bullish that this drug will reshape the market for flu drugs when it is released.

MultiCell Technologies, Inc. (MCET.OB: 0.0124 +24.00%) shares surged more than 50 percent as investors seemed to recall its past press releases focused on the avian flu. The press release, dated October 21, 2005, announced pre-clinical test results showing positive results for H1N1 flu strains – the same strain as the swine flu. Shareholders are bullish that the company’s toll receptor technology will be able to show similar effectiveness with the swine flu.

Kiwa Bio-Tech Products Group Corporation (KWBTE.OB: 0.0025 +212.50%) shares jumped more than 200 percent as investors recalled its past work with the avian bird flu. A few years ago, the company formed a joint venture to develop Kiwa’s AF-01 anti-viral preventative for avian flu. Investors are bullish on the drugs future prospects, despite the fact that the company only intended to develop it to target animal holding facilities to treat animals.

For commentary and Kirk Lindstrom current outlook for NNVC, read "Kirk's Investment Newsletter"

• NNVC Charts
  
  
• FREE Sample Issue of "Kirk Lindstrom's Investment Letter"
  

NNVC PRICES

Date	Close $	Volume
24-Apr-09	0.80	206,600
23-Apr-09	0.68	26,900
22-Apr-09	0.70	86,600
21-Apr-09	0.73	240,500
20-Apr-09	0.60	40,300
17-Apr-09	0.60	59,400
16-Apr-09	0.60	21,500

Jim Cramer Advice "The Flip-Flop that Ought to be Illegal"

Jim Cramer was quite bullish for beaten down sectors a couple of weeks ago including home builders. ON Friday June 13 he said to BUY banks and Retailers. A week later, on Friday June 20 2008, he said if you bought them you're not listening.

He also said to avoid oil and oil related stocks. A week later on June 20th these oil related stocks were up and he said to keep buying what was working so far. He seemed to take credit for "the petroleum complex" as "the ONLY green in a sea of red."

Video Title: "The Flip-Flop that Ought to be Illegal"



Huh? How does one follow this sort of "advice?